|
Market Closed -
Nasdaq
23:00:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.900 USD | +1.14% |
|
+8.14% | +33.07% |
| 10-06 | Harvard Bioscience, Inc. Announces Creation of Scientific Advisory Board | CI |
| 08-11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 40.52M 36.29M 33.38M 30.24M 56.53M 3.85B 57.59M 398M 160M 2.02B 152M 149M 6.38B | P/E 2026 * |
-4.58x | P/E 2027 * | -19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 40.52M 36.29M 33.38M 30.24M 56.53M 3.85B 57.59M 398M 160M 2.02B 152M 149M 6.38B | EV / Sales 2026 * |
0.45x | EV / Sales 2027 * | 0.43x |
| Free-Float |
90.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HBIO | Delayed | |
CBOE
| HBIO | Real-time |
Last Transcript: Harvard Bioscience, Inc.
| 1 day | +1.14% | ||
| 1 week | +8.14% | ||
| Current month | +12.37% | ||
| 1 month | +12.37% | ||
| 3 months | +46.14% | ||
| 6 months | +39.50% | ||
| Current year | +33.07% |
| 1 week | 8.17 |  | 9 |
| 1 month | 7.9 | | 9 |
| Current year | 4 | | 9 |
| 1 year | 4 | | 9 |
| 3 years | 2.81 | | 55.6 |
| 5 years | 2.81 | | 82.3 |
| 10 years | 2.81 | | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Duke
CEO | Chief Executive Officer | 55 | 28/07/2025 |
Mark Frost
DFI | Director of Finance/CFO | 63 | 12/05/2025 |
Diane Houston
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Katherine Eade
BRD | Director/Board Member | 52 | 24/10/2017 |
John Duke
BRD | Director/Board Member | 55 | 02/06/2025 |
Robert Gagnon
BRD | Director/Board Member | 52 | 16/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/20/26 A | Free | Chief Executive Officer | 75,000 | 0.1677% | ||
| 3/20/26 A | Free | Chief Financial Officer | 30,000 | 0.0671% | ||
| 3/17/26 A | Buy | Director | 10,000 | 0.0224% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | +8.14% | +41.27% | -79.16% | 40.52M | |
| -1.72% | +3.44% | +25.31% | +60.56% | 258B | |
| -2.00% | +0.75% | +7.99% | +25.46% | 163B | |
| -3.73% | -4.48% | -18.49% | +67.13% | 150B | |
| -1.66% | -8.12% | -58.26% | -16.12% | 60.84B | |
| -2.57% | +3.30% | +10.22% | +47.55% | 53.03B | |
| 0.00% | +2.46% | -11.97% | -6.29% | 53.31B | |
| -3.47% | +1.04% | +21.98% | +72.85% | 49.3B | |
| +0.84% | -3.12% | +9.80% | +64.47% | 50.67B | |
| -3.61% | +1.99% | +34.94% | +95.49% | 45.46B | |
| Average | -1.68% | +0.54% | +6.28% | +33.19% | 88.35B | |
| Weighted average by Cap. | -2.10% | +0.15% | +5.19% | +47.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 89.8M 80.42M 73.98M 67.03M 125M 8.53B 128M 882M 354M 4.49B 337M 330M 14.14B | 94.55M 84.68M 77.89M 70.58M 132M 8.98B 134M 929M 373M 4.72B 355M 347M 14.89B |
| Net income | -8.9M -7.97M -7.33M -6.64M -12.42M -845M -12.65M -87.43M -35.1M -445M -33.4M -32.69M -1.4B | -2.2M -1.97M -1.81M -1.64M -3.07M -209M -3.13M -21.61M -8.68M -110M -8.26M -8.08M -347M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $8.900 | +1.14% | 23,170 |
| 29/10/26 | $8.800 | +4.51% | 49,998 |
| 28/10/26 | $8.420 | +0.84% | 7,987 |
| 27/10/26 | $8.350 | +0.36% | 6,049 |
| 26/10/26 | $8.320 | +1.09% | 24,338 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HBIO Stock
Select your edition
All financial news and data tailored to specific country editions
